Cite
MLA Citation
Ja Bae et al.. “Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.” Diagnostic pathology, vol. 11, no. 1, 2016, pp. 1–10. http://access.bl.uk/ark:/81055/vdc_100080430213.0x0000ba